APM
RPRX icon

Advanced Portfolio Management’s Royalty Pharma RPRX Stock Holding History

Advanced Portfolio Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-140,000
Closed -$3.96M – 70
2024
Q3 		$3.96M Sell
140,000
-100,000
-42% -$2.77M 4.08% 9
2024
Q2 		$6.33M Buy
240,000
+120,000
+100% +$3.33M 4.17% 6
2024
Q1 		$3.64M Sell
120,000
-15,000
-11% -$442K 6.88% 3
2023
Q4 		$3.79M Sell
135,000
-95,000
-41% -$2.61M 3.99% 4
2023
Q3 		$6.24M Buy
230,000
+80,000
+53% +$2.38M 5.25% 2
2023
Q2 		$4.61M Buy
+150,000
New +$5.08M 4.2% 7

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advanced Portfolio Management's RPRX Position: Q4 2024 in Review

Advanced Portfolio Management sold out of Royalty Pharma (RPRX) in Q4 2024, closing a stake of 140,000 shares — an estimated $3.96M sold.

Advanced Portfolio Management first reported a position in RPRX in Q2 2023 and held it in 6 quarters. The position peaked at $6.33M in Q2 2024. 417 funds tracked by Wall St. Rank hold RPRX as of Q4 2024.

  • Advanced Portfolio Management reported no remaining Royalty Pharma position as of Q4 2024 after selling out during the quarter.
  • Advanced Portfolio Management sold 140,000 Royalty Pharma shares in Q4 2024, an estimated $3.96M.
  • Advanced Portfolio Management first reported a position in Royalty Pharma in Q2 2023 and held it in 6 quarters.
  • Advanced Portfolio Management's Royalty Pharma position peaked at $6.33M in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2024.

Based on Advanced Portfolio Management's 13F filing for Q4 2024, filed 14 Feb 2025.